Healthcare provider profile · identity verified

Stephen Paul Vogt, MD

Hospitalist · HOOD RIVER, OR · NPI 1205927142

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	543	137
Potassium Chloride	Potassium Chloride	296	75
Levothyroxine Sodium	Levothyroxine Sodium	250	63
Amlodipine Besylate	Amlodipine Besylate	228	61
Losartan Potassium	Losartan Potassium	220	58
Eliquis	Apixaban	211	38
Lisinopril	Lisinopril	202	58
Metoprolol Succinate	Metoprolol Succinate	200	52
Tamsulosin Hcl	Tamsulosin Hcl	174	46
Omeprazole	Omeprazole	171	48
Hydrochlorothiazide	Hydrochlorothiazide	145	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	139	30
Trazodone Hcl	Trazodone Hcl	134	32
Simvastatin	Simvastatin	123	33
Furosemide	Furosemide	118	29
Gabapentin	Gabapentin	104	27
Fluoxetine Hcl	Fluoxetine Hcl	100	25
Rosuvastatin Calcium	Rosuvastatin Calcium	98	30
Pantoprazole Sodium	Pantoprazole Sodium	86	18
Citalopram Hbr	Citalopram Hydrobromide	79	20
Zolpidem Tartrate	Zolpidem Tartrate	78	24
Metformin Hcl	Metformin Hcl	75	22
Alendronate Sodium	Alendronate Sodium	73	21
Oxycodone Hcl	Oxycodone Hcl	72	23
Finasteride	Finasteride	71	18
Metformin Hcl Er	Metformin Hcl	69	17
Metoprolol Tartrate	Metoprolol Tartrate	69	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	16
Spironolactone	Spironolactone	56	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	16
Albuterol Sulfate Hfa	Albuterol Sulfate	49	27
Allopurinol	Allopurinol	47	12
Warfarin Sodium	Warfarin Sodium	47	13
Pravastatin Sodium	Pravastatin Sodium	44	14
Mirtazapine	Mirtazapine	41	11
Celecoxib	Celecoxib	38	12
Prednisone	Prednisone	38	13
Jardiance	Empagliflozin	36	suppressed
Atenolol	Atenolol	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	14
Glipizide Er	Glipizide	34	suppressed
Lovastatin	Lovastatin	33	11
Synthroid	Levothyroxine Sodium	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Acyclovir	Acyclovir	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Ozempic	Semaglutide	26	suppressed
Alprazolam	Alprazolam	25	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Sertraline Hcl	Sertraline Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	11
Entresto	Sacubitril/Valsartan	21	suppressed
Nitroglycerin	Nitroglycerin	21	16
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Nystatin	Nystatin	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Donepezil Hcl	Donepezil Hcl	18	suppressed
Estradiol	Estradiol	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Chlorthalidone	Chlorthalidone	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Nystop	Nystatin	14	suppressed
Ondansetron Odt	Ondansetron	14	11
Torsemide	Torsemide	14	suppressed
Azithromycin	Azithromycin	13	11
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Famotidine	Famotidine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Felodipine Er	Felodipine	11	suppressed
Glipizide	Glipizide	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Valproic Acid	Valproic Acid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error